Dr. John Oertle of Envita Medical Centers Spreads Awareness About Sarcomas on The Mike Schikman Show
Sarcomas are considered rare cancers, but they can be very resistant to chemotherapy and radiation. “This is true for all cancers, but particularly for sarcomas,” said Dr. John Oertle, Chief Medical Director, Envita Medical Centers and Envita Health. Speaking at the Mike Schikman Show on “Sarcoma Awareness Month,” Dr. Oertle explained that sarcomas develop in bones and soft tissues and can be found in any part of the body, except organs.
The Envita team has been able to successfully treat many patients with late-stage sarcomas, because their doctors go beyond standard chemotherapy and radiation, by utilizing personalized precision integrative oncology treatments. Reiterating the role of precision oncology in cancer treatment, Dr. Oertle said that it helps to identify the root causative factors responsible for triggering the growth and development of disease in each individual patient. Equipped with such detailed information about each patient's sarcoma, the Envita team is able to custom-develop unique treatment protocols for each individual patient. These protocols aim at not only targeting the disease, but also treating its source to prevent chances of recurrence or metastasis.
Precision medicine helps to treat not just the tumor or the disease, but it unravels and proactively treats the causes responsible for the growth and proliferation of disease. This comprehensively personalized approach to treatment enables team Envita to deliver the most appropriate medications targeted at the disease core, helping to reduce the chances of disease recurrence and metastases.
“Remove the source of the fuel so now you can start to treat the forest fire,” added Dr. Oertle, while explaining the guiding principle behind the proprietary precision integrative oncology treatments practiced at Envita. The team has 25 years of experience in practicing this advanced oncology approach, which has proved beneficial for cancer and sarcoma patients, many of whom were left with limited options in noted cancer treatment facilities of the country.
To know more about sarcomas and how you can get coverage for prevention and treatment of sarcomas and other cancers, listen to this radio interview.
